Abstract
1 The ability of various prostaglandins (PGs) to inhibit monocyte chemotaxis induced by monocyte chemoattractant protein-1 (MCP-1) was investigated with a human monocytic leukaemia cell line, THP-1. Moreover, to investigate the mechanism of the inhibitory action of PGs the involvement of either intracellular adenosine 3': 5'-cyclic monosphosphate (cyclic AMP) accumulation or intracellular Ca2+ mobilization was studied. 2 TEI-6122, a synthetic 7-thia-PGE1 derivative, inhibited chemotaxis of THP-1 cells induced by MCP-1 with an IC50 of 1.5 pM. Its inhibitory activity was 1000 fold more than that of PGE1 and PGE2 (IC50 = 2.8 nM and 0.9 nM, respectively), which were more potent than other PGs such as PGA1, PGA2, PGF2 alpha and PGI2 (IC50 > or = 1 microM). 3 With respect to the effect on intracellular cyclic AMP accumulation in THP-1 cells, TEI-6122 was as potent as PGE1 and PGE2, which were approximately 100 to 1000 fold more potent than the other PGs such as PGA1, PGA2 and PGI2. The minimum concentration of TEI-6122 required to increase intracellular cyclic AMP accumulation in THP-1 cells was 1 nM. 4 TEI-6122 and PGE1 (4 microM) transiently increased intracellular calcium levels in THP-1 cells. When added prior to MCP-1, both PGs partially suppressed the increased in Ca2+ caused by this cytokine. There were no significant differences between the activity of TEI-6122 and PGE1 in either respect. 5 It is concluded that TEI-6122, a synthetic 7-thia-PGE1 derivative is a much more potent inhibitor of MCP-1-induced THP-1 cell chemotaxis than PGEI and PGE2 which are the best inhibitors among the natural PGs tested, while neither intracellular cyclic AMP accumulation nor effects on Ca2+ mobilization account for the extremely potent inhibitory activity of TEI-6122. Thus, either a novel PGE2 receptor (EPreceptor) or a novel intracellular signal transduction system may be involved in the extremely potent chemotaxis inhibitory activity of TEI-6122.
MeSH Terms
Alprostadil/analogs & derivatives,pharmacology
Calcium/metabolism
Chemokine CCL2/antagonists & inhibitors,pharmacology
Chemotaxis, Leukocyte/drug effects
Cyclic AMP/metabolism
Fibrinolytic Agents/pharmacology
Humans
Kinetics
Leukemia, Monocytic, Acute/metabolism,physiopathology
Tumor Cells, Cultured
Chemicals
Chemokine CCL2
Fibrinolytic Agents
TFC 612
Cyclic AMP
Alprostadil
Calcium
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tanaka H
Pharmaceutical Discovery Research Laboratories, Teijin Institute for Biomedical Research, Tokyo, Japan.
Minoshima T
Endo N
References (33)
33 references, click to expand
-
Monocyte chemoattractant protein-1 in human atheromatous plaques.
J Clin Invest. 1991 Oct;88(4):1121-7
PMID: 1843454
-
Full active baculovirus-expressed human monocyte chemoattractant protein 1 with the intact N-terminus.
Biochem Biophys Res Commun. 1995 Jan 26;206(3):955-61
PMID: 7832810
-
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.
J Biol Chem. 1992 Apr 5;267(10):6463-6
PMID: 1372606
-
Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.
J Immunol. 1992 Jun 1;148(11):3441-5
PMID: 1350291
-
Effect of prostaglandin E 1 on adjuvant arthritis.
Nature. 1971 Dec 3;234(5327):304-5
PMID: 5003042
-
A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration.
J Immunol Methods. 1980;33(3):239-47
PMID: 6989919
-
Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil.
J Immunol. 1983 Apr;130(4):1495-7
PMID: 6300229
-
Synthesis of 7-thiaprostaglandin E1 congeners: potent inhibitors of platelet aggregation.
Chem Pharm Bull (Tokyo). 1985 Jun;33(6):2359-85
PMID: 4064196
-
Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis.
J Clin Invest. 1987 Mar;79(3):782-9
PMID: 2950135
-
Thromboxane, prostaglandin and leukotriene receptors.
Annu Rev Pharmacol Toxicol. 1989;29:213-39
PMID: 2543270
-
Prostaglandin E1 suppresses macrophage infiltration and ameliorates injury in an experimental model of macrophage-dependent glomerulonephritis.
Clin Exp Immunol. 1990 Feb;79(2):260-5
PMID: 2311303
-
Human monocyte chemoattractant protein-1 (MCP-1).
Immunol Today. 1990 Mar;11(3):97-101
PMID: 2186747
-
cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness.
J Immunol. 1991 Jan 1;146(1):224-32
PMID: 1701793
-
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5252-6
PMID: 2052604
-
Properties of the novel proinflammatory supergene "intercrine" cytokine family.
Annu Rev Immunol. 1991;9:617-48
PMID: 1910690
-
Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells.
Arterioscler Thromb. 1991 Sep-Oct;11(5):1166-74
PMID: 1911703
-
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes.
J Immunol. 1992 Jul 15;149(2):722-7
PMID: 1624809
-
Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates.
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6953-7
PMID: 1379728
-
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.
J Clin Invest. 1992 Sep;90(3):772-9
PMID: 1522232
-
13,14-Dihydro-prostaglandin E1 decreases low-density lipoprotein influx into rabbit aorta.
Eur J Pharmacol. 1992 Aug 14;219(1):129-33
PMID: 1397039
-
Receptor-activated calcium influx in human monocytes exposed to monocyte chemotactic protein-1 and related cytokines.
J Immunol. 1993 Feb 15;150(4):1544-53
PMID: 7679430
-
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.
J Biol Chem. 1993 Apr 15;268(11):7759-62
PMID: 8385118
-
Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts.
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6086-90
PMID: 8327487
-
Modulation of the kinetics of the initial leukocyte migration into renal allografts by 16,16-dimethyl PGE2.
Transplantation. 1993 Aug;56(2):417-22
PMID: 8356599
-
Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor.
J Biol Chem. 1993 Sep 25;268(27):20175-8
PMID: 7690750
-
Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2.
Biochem Biophys Res Commun. 1993 Nov 30;197(1):263-70
PMID: 8250933
-
Antiatherosclerotic effects of oral cicaprost in experimental hypercholesterolemia in rabbits.
Atherosclerosis. 1993 Oct;103(1):93-105
PMID: 8280189
-
A novel inhibitory prostanoid receptor in piglet saphenous vein.
Prostaglandins. 1994 Feb;47(2):151-68
PMID: 8016385
-
cDNA cloning and functional expression of a human monocyte chemoattractant protein 1 receptor.
Biochem Biophys Res Commun. 1994 Jul 29;202(2):1156-62
PMID: 8048929
-
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
Mol Pharmacol. 1994 Aug;46(2):213-20
PMID: 8078484
-
Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.
Lab Invest. 1994 Oct;71(4):536-42
PMID: 7967509
-
Effect of TFC-612, a 7-thia prostaglandin E1 derivative, on intimal thickening after endothelial injury with balloon catheter in rats.
Atherosclerosis. 1994 Aug;108(2):159-65
PMID: 7980715
-
The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine.
J Immunol. 1991 Oct 1;147(7):2215-21
PMID: 1918957